Pro Medicus Limited ( (AU:PME) ) just unveiled an announcement.
Pro Medicus Limited has announced an update regarding its ongoing on-market buy-back program. As of April 7, 2025, the company has repurchased a total of 7,648 ordinary fully paid securities, including 2,610 bought back on the previous day. This buy-back initiative is part of Pro Medicus’s strategy to manage its capital structure and potentially enhance shareholder value.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare industry, focusing on providing medical imaging software and services. The company is known for its advanced imaging solutions that cater to hospitals and healthcare providers, enhancing diagnostic capabilities and operational efficiency.
YTD Price Performance: -32.31%
Average Trading Volume: 472
Technical Sentiment Signal: Sell
Current Market Cap: $11.98B
For an in-depth examination of PME stock, go to TipRanks’ Stock Analysis page.